JP2016516728A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516728A5
JP2016516728A5 JP2016503388A JP2016503388A JP2016516728A5 JP 2016516728 A5 JP2016516728 A5 JP 2016516728A5 JP 2016503388 A JP2016503388 A JP 2016503388A JP 2016503388 A JP2016503388 A JP 2016503388A JP 2016516728 A5 JP2016516728 A5 JP 2016516728A5
Authority
JP
Japan
Prior art keywords
patent document
insulin
international publication
international
publication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016503388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516728A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/030387 external-priority patent/WO2014145593A2/en
Publication of JP2016516728A publication Critical patent/JP2016516728A/ja
Publication of JP2016516728A5 publication Critical patent/JP2016516728A5/ja
Pending legal-status Critical Current

Links

JP2016503388A 2013-03-15 2014-03-17 第2部位インスリン類似体 Pending JP2016516728A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798165P 2013-03-15 2013-03-15
US61/798,165 2013-03-15
PCT/US2014/030387 WO2014145593A2 (en) 2013-03-15 2014-03-17 Site 2 insulin analogues

Publications (2)

Publication Number Publication Date
JP2016516728A JP2016516728A (ja) 2016-06-09
JP2016516728A5 true JP2016516728A5 (enExample) 2017-03-30

Family

ID=51538504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016503388A Pending JP2016516728A (ja) 2013-03-15 2014-03-17 第2部位インスリン類似体

Country Status (10)

Country Link
US (1) US20160083448A1 (enExample)
EP (1) EP2968473A4 (enExample)
JP (1) JP2016516728A (enExample)
KR (1) KR20150138251A (enExample)
CN (1) CN105228643A (enExample)
AU (1) AU2014232894B2 (enExample)
BR (1) BR112015023672A2 (enExample)
CA (1) CA2942524A1 (enExample)
IL (1) IL241357B (enExample)
WO (1) WO2014145593A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2936563A1 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
JP2018505874A (ja) * 2015-01-20 2018-03-01 ケース ウェスタン リザーブ ユニバーシティCase Western Reserve University 選択的シグナリング特性及びより低い分裂促進性を有するインスリンアナログ
JP7143275B2 (ja) 2016-07-22 2022-09-28 ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション インスリンアナログ
CN109891237B (zh) * 2016-10-24 2022-08-23 诺和诺德股份有限公司 胰岛素制剂的生物测定法
AU2017361524B2 (en) * 2016-11-21 2022-06-02 Case Western Reserve University Rapid-acting insulin analogues of enhanced stability
BR112021005366A2 (pt) * 2018-09-21 2021-06-29 Case Western Reserve University análogo de insulina de cadeia simples, uso deste e método para reduzir o açúcar no sangue de um paciente
WO2024218715A1 (en) 2023-04-19 2024-10-24 Btl Healthcare Technologies A.S. Culture media based on protein hydrolysate and a process for preparing thereof
US12668774B2 (en) 2023-10-12 2026-06-30 Btl Healthcare Technologies A.S. Product, system and method of cell cultivation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK158390D0 (da) * 1990-07-02 1990-07-02 Novo Nordisk As Nye peptider
DK10191D0 (da) * 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
DK33591D0 (enExample) * 1991-02-27 1991-02-27 Novo Nordisk As
CN101573133B (zh) 2006-07-31 2014-08-27 诺沃-诺迪斯克有限公司 Peg化延长的胰岛素
EP2074140B8 (en) 2006-10-04 2015-10-28 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
WO2009129250A2 (en) * 2008-04-14 2009-10-22 Case Western Reserve University Meal-time insulin analogues of enhanced stability
AU2009240636A1 (en) * 2008-04-22 2009-10-29 Case Western Reserve University Isoform-specific insulin analogues
EP2318432B1 (en) * 2008-07-31 2015-09-02 Case Western Reserve University Halogen-stabilized insulin

Similar Documents

Publication Publication Date Title
ES2540858T3 (es) Composición farmacéutica para el tratamiento y/o la prevención de cáncer
ES2606173T3 (es) Composición farmacéutica para el tratamiento y/o la prevención del cáncer
CY1125109T1 (el) Θεραπειες toy καρκινου
AR092076A1 (es) Proteinas homodimericas
BR112016020688A2 (pt) Composições úteis no tratamento da deficiência da ornitina transcarbamilase (otc)
CY1117603T1 (el) Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2
EA201790858A3 (ru) Лечение и профилактика амилоидоза
SG10201901482XA (en) Oncolytic adenovirus encoding a b7 protein
EA201370178A1 (ru) Стабильные составы для парентеральной инъекции пептидных лекарственных средств
EA201891946A1 (ru) Коагонисты глюкагона и glp-1 для лечения ожирения
EA201892671A1 (ru) Пегилированный свиной интерферон и способы его применения
EA201600418A1 (ru) Новые иммуноконъюгаты
MX395257B (es) Anticuerpos para cd40.
CY1116728T1 (el) Παραγοντες οι οποιοι επαγουν αποπτωση για την αντιμετωπιση καρκινου και ανοσολογικων και αυτοανοσων νοσηματων
EA201500802A1 (ru) Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы
BR112014032938A2 (pt) uso de peptídeos de glp-1 de longa ação
MX380597B (es) Composición con complejos de nanopartículas/anticuerpos de paclitaxel unidos a albúmina para usarse al tratar linfoma.
AR087693A1 (es) Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
MX362527B (es) Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
CL2019003422A1 (es) Nuevos péptidos (seq id n°171), combinaciones de péptidos y soportes para el uso en el tratamiento inmunoterapéutico de varios tipos de cáncer. (divisional solicitud 201800545)
RU2017116973A (ru) Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса
MX389091B (es) Tratamiento de pacientes con diabetes mellitus de tipo 2.
EA201491369A1 (ru) Способ лечения сахарного диабета при помощи негликозилированного аполипопротеина a-iv
MY159255A (en) Antigen binding proteins specific for serum amyloid p component
EA201691498A1 (ru) Новая мишень для лечения и профилактики диабета